Brief: Innovative Pharmaceutical Biotech Posts FY Revenue HK$15.8 MLN
June 29 (Reuters) - Innovative Pharmaceutical Biotech Ltd
0399.HK :
* FY REVENUE HK$15.8 MILLION VERSUS HK$9.2 MILLION
* LOSS FOR YEAR ATTRIBUTABLE HK$231.0 MILLION VERSUS LOSS OF
HK$169.8 MILLION
Source text for Eikon: ID:nHKS46Xd9g
Further company coverage: 0399.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starcoin
See all newsBrief: Starcoin Group Says Trading In Shares Of Co Will Suspend From 6 May
Brief: Starcoin Enters Non-Binding Memorandum Of Understanding With Marvel Nice
Brief: Starcoin Group Enters MoU For Strategic Cooperation With Huamei Haibo Biotechnology (Chongqing)
Brief: Starcoin Group Says Unit, Others Enters Deal For Brazilian Gold Mine RWA Tokenization
Brief: Starcoin Group, Newbridge And Conflux Foundation Entered MoU